Related Experiment Video
Updated: Jun 23, 2026
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Recent advances in neuroblastoma
1Department of Surgery, The University of Texas Medical Branch, Galveston, TX 77555-0353, USA
Purpose Of Review:
Although there have been recent advances with multimodal therapy, treatment of neuroblastoma remains a clinical challenge. Despite the identification of several genetic features, there has not been a significant increase in 5-year survival in the last decade. This review will highlight the current operative strategies along with new research developments aimed at improving survival.
Recent Findings:
The goal of surgical intervention in the early stages of neuroblastoma is complete curative resection. In advanced-stage disease, tissue biopsy for staging is the initial goal. In recent years, minimally invasive surgery (MIS) is considered in carefully selected patients. Recent advances in neuroblastoma research have focused on tyrosine kinase inhibition, differentiation, pathway inhibition, and immunotherapy. Several of these targets have shown promising results in vivo and are currently under investigation for potential clinical trials.
Summary:
New information on the importance of cell signaling and the targeting of specific genes of interest are providing key insights into neuroblastoma. Only through the discovery of novel treatment strategies made available through the advancement of research will neuroblastoma be survivable for patients with advanced-stage disease.
Insights
Treatment for neuroblastoma remains challenging, with limited survival improvements. New research into targeted therapies and surgical approaches offers hope for better outcomes in neuroblastoma patients.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Translational Cancer Research
Background:
- Neuroblastoma treatment remains a significant clinical challenge, with stagnant 5-year survival rates despite multimodal therapy advancements.
- Identification of genetic features has not yet translated into substantial survival gains for neuroblastoma patients.
- Current research focuses on novel therapeutic targets and refined surgical strategies to improve outcomes.
Purpose of the Study:
- To review current operative strategies for neuroblastoma treatment.
- To highlight recent research developments aimed at improving neuroblastoma survival rates.
- To discuss the potential of new therapeutic targets in managing advanced-stage neuroblastoma.
Main Methods:
- Review of current literature on neuroblastoma surgical interventions.
- Analysis of recent research findings in neuroblastoma targeted therapies.
- Discussion of emerging treatment modalities including tyrosine kinase inhibition, differentiation agents, pathway inhibitors, and immunotherapy.
Main Results:
- Complete curative resection is the primary goal in early-stage neuroblastoma; tissue biopsy is crucial for staging in advanced disease.
- Minimally invasive surgery (MIS) is increasingly considered for select neuroblastoma patients.
- Promising preclinical results have been observed with novel agents targeting tyrosine kinases, differentiation pathways, and immunotherapy.
Conclusions:
- Understanding cell signaling and targeting specific genes are crucial for advancing neuroblastoma treatment.
- Novel treatment strategies derived from ongoing research are essential for improving survival in advanced-stage neuroblastoma.
- Continued research into targeted therapies and surgical techniques is vital for overcoming the challenges in neuroblastoma management.
